Scheinbart L S, Johnson M A, Gross L A, Edelstein S R, Richardson B C
Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0531.
J Rheumatol. 1991 Apr;18(4):530-4.
Procainamide, a widely used antiarrythmic, causes DNA hypomethylation in the human T cell line Jurkat, but the mechanism is unknown. We report that procainamide inhibits the DNA methyltransferase catalyzed transfer of methyl groups from S-adenosylmethionine to DNA, but has no effect on other known regulators of DNA methylation. Our results suggest that procainamide could inhibit cellular DNA methylation by inhibiting DNA methyltransferase activity.